Latest return on equity
ArriVent BioPharma Return on equity
Direct answer
ArriVent BioPharma's return on equity is -53.25%.
The verified market snapshot reports -53.25%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 24, 2026.
Get free ArriVent BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -53.25%
Explore related company data
View ArriVent BioPharma's market capitalizationView ArriVent BioPharma's price-to-book ratioView ArriVent BioPharma's dividend yieldView ArriVent BioPharma's 52-week price rangeView ArriVent BioPharma's profit marginView ArriVent BioPharma's debt-to-equity ratioView all ArriVent BioPharma key metricsReturn to ArriVent BioPharma profile